PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Nov-2024 BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations BrightHeart
18-Nov-2024 ICR Healthcare and Sponsors Host 12th Annual Healthcare Conference: Development, Deals and Dollars ICR Healthcare
18-Nov-2024 Update on Financial Position Celadon Pharmaceuticals Plc
18-Nov-2024 The King’s Fund calls on NHS leaders to help unlock power of industry partnerships ABPI
18-Nov-2024 iiCON funds 11 new innovative projects focused on tackling infectious diseases iiCON
18-Nov-2024 UK Regulator MHRA Grants Nanomerics Clinical Trials Authorisation Notice for its Upcoming OC134 Clinical Trial AccessWire
18-Nov-2024 Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama® Formycon AG
18-Nov-2024 Better Mental Healthcare Outcomes for Implementing Patient-Engaging Solutions Research Nester
18-Nov-2024 Proregulations Launches U.S. Drug Master File Document Production and Filing Service Proregulations
18-Nov-2024 Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities Protheragen-ING
18-Nov-2024 Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development Protheragen-ING
18-Nov-2024 Hometown NP Expands Telepsychiatry Services to 39 States Nationwide AccessWire
18-Nov-2024 CD Formulation Emphasizes Compatibility Studies Between Drug Formulation and Packaging CD Formulation
18-Nov-2024 Alfa Chemistry Integrates Its Product Portfolio of Light Stabilizers, Alumina Catalyst Carriers, and More Alfa Chemistry
16-Nov-2024 Stars Shine at Beverly Hills Gala by Beauty-Stem: Advancing Health Innovations and Cancer Research AccessWire
15-Nov-2024 Accelerating Demand for Specialized RCM Solutions in Outpatient and Ancillary Services Set to Surge in 2025, Reports Black Book Research AccessWire
15-Nov-2024 Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA Formycon AG
15-Nov-2024 Quotient Sciences Announces Installation of World's First GMP Biofoundry-in-a-Box™ from Centillion Technology Quotient Sciences
15-Nov-2024 CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer Janssen-Cilag International NV
15-Nov-2024 THIRA Health Welcomes Patricia Charles-Heathers, Ph.D., MPA, as New Executive Director AccessWire